Skip to main content

Table 1. Antibodies applied in this study

From: Febrile temperature-regulated TRPV1 in CD4+ T cells mediates neuroinflammation in complex febrile seizures

 

Manufacture

Dilution

Primary antibody

Anti-CD4

Abcam (ab133616)

1:200 (IF)

Anti-IL-17A

Abcam (ab318150)

1:200 (IF)

Anti-TRPV4

Affinity (DF8624)

1:500 (WB)

1:200 (IF)

Anti-TRPV1

Affinity (DF10320)

1:500 (WB)

1:200 (IF)

Anti-NFAT2

Novus (NB300-504)

1:200 (IF)

Anti-NFAT4

Affinity (AF6240)

1:200 (IF)

Anti-STAT3

Proteintech (10253-2-AP)

1:500 (WB)

Anti-P-STAT3

CST (9145)

1:1000 (WB)

1:200 (IF)

Anti-ZO-1

Proteintech (21773-1-AP)

1:1000 (WB)

Anti-Ocldn

Proteintech (27260-1-AP)

1:1000 (WB)

Anti-Cldn5

Affinity (AF5216)

1:1000 (WB)

Anti-IBA1

CST (17198S)

1:1000 (WB)

1:200 (IF)

Anti-CD68

Proteintech (28058-1-AP)

1:1000 (WB)

1:200 (IF)

Anti-P38

Proteintech (14064-1-AP)

1:1000 (WB)

Anti-P-P38

Proteintech (28796-1-AP)

1:1000 (WB)

Anti-IL-6

Bioss (bs-0782R)

1:500 (WB)

Anti-TNF-α

ABclonal (A0277)

1:500 (WB)

Anti-β-actin

Proteintech (66009-1-Ig)

1:5000 (WB)

Anti-GAPDH

Proteintech (66004-1-Ig)

1:5000 (WB)

Secondary antibody

Goat anti-mouse IgG

Biosharp(BL001A)

1:10000 (WB)

Goat anti-rabbit IgG

Biosharp(BL003A)

1:10000 (WB)